Melatonin biological activity and binding sites in human melanoma cells

Journal of Pineal Research

Volumn 34, Issue 4, 2003, Pages 242-248

  De Souza, Andrea Vieira ^a   Visconti, Maria Aparecida ^a   De Lauro Castrucci, Ana Maria ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cell proliferation; Human melanoma; Luzindole; Melatonin; N acetylserotonin; Prazosin; Tyrosinase activity

Indexed keywords

2 IODOMELATONIN; INDOLEAMINE; IODINE 125; LUZINDOLE; MELATONIN; MONOPHENOL MONOOXYGENASE; N ACETYLSEROTONIN; PRAZOSIN; SEROTONIN;

ARTICLE; BINDING ASSAY; CANCER CELL CULTURE; CANCER GROWTH; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG BINDING SITE; DRUG EFFECT; DRUG POTENCY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MELANOGENESIS; MELANOMA;

EID: 0037404884     PISSN: 07423098     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-079x.2003.02928.x     Document Type: Article

References (44)

1. BINKLEY S. The pineal: evidence and neuroendocrine function. Prentice Hall, Englewood Cliffs, 1988; 304 pp.
2. REITER RJ. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocrine Rev 1991; 12:151-180.
3. BECKER-ANDRE M, WIESENBERG I, SCHAEREN-WIEMERS N et al. Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor family. J Biol Chem 1994; 269:28531-28534.
4. BECKER-ANDRE M, WIESENBERG I, SCHAEREN-WIEMERS N et al. Additions and corrections to "Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor family". J Biol Chem 1997; 272:16707.
5. STEINHILBER D, BRUNGS M, WERZ O et al. The nuclear receptor for melatonin represses 5-lipoxygenase gene expression in human B lymphocytes. J Biol Chem 1995; 31:7037-7040.
6. GUERRERO JM, POZO D, GARCIA-MAURINO S, CARRILLO A, OSUNA C, MOLINERO P, CALVO JR. Nuclear receptors are involved in the enhanced IL-6 production of melatonin in U397 cells. Biol Signal Receptors 2000; 9:197-202.
7. BALER R, COON S, KLEIN DC. Orphan nuclear receptor RZRβ: cyclic AMP regulates expression in the pineal gland. Biochem Biophys Res Commun 1996; 220:975-978.
8. PARK HT, BAEK SY, KIM BS, KIM JB, KIM JJ. Developmental expression of 'RZRβ, a putative nuclear melatonin receptor' mRNA in the suprachiasmatic nucleus of the rat. Neurosci Lett 1996; 217:17-20.
9. REPPERT SM, WEAVER DR, EBISAWA T. Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron 1994; 13:1177-1185.
10. REPPERT SM, GODSON C, MAHLE CD, WEAVER DR, SLAUGENHAUPT SA, GUSELLA JF. Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor. Proc Natl Acad Sci USA 1995; 92:8734-8738.
11. EBISAWA T, KARNE S, LERNER MR, REPPERT SM. Expression cloning of a high-affinity melatonin receptor from Xenopus dermal melanophores. Proc Natl Acad Sci USA 1994; 91:6133-6137.
12. REPPERT SM. Melatonin receptors: molecular biology of a new family of G protein-coupled receptors. J Biol Rhythms 1997; 12:528-531.
13. SHIU SYW, PANG SF. An updated phylogenetic analysis of vertebrate melatonin receptor sequences: reflection on the melatonin receptor nomenclature by the Nomenclature Subcomittee of the International Union of Pharmacology. Biol Signals Recept 1998; 7:244-248.
14. DUBOCOVICH ML. Melatonin receptors: are there multiple subtypes? Trends Pharmacol Sci 1995; 16:50-56.
15. 3 as the quinone reductase 2. J Biol Chem 2000; 10:1074.
16. z proteins. FEBS Lett 1995; 372:99-102.
17. q/11 proteins. Mol Endocrinol 1999; 13:2025-2038.
18. BLUMENAU C, BERGER E, FAUTECK JD et al. Expression and functional characterization of the mt1 melatonin receptor from rat brain in Xenopus oocytes: evidence for coupling to the phosphoinositol pathway. J Pineal Res 2001; 30:139-146.
19. POMERANTZ SH. The tyrosine hydroxilase activity of mammalian tyrosinase. J Biol Chem 1969; 241:161-168.
20. MENGEAUD V, ORTONNE JP. Regulation of melanogenesis induced by 5′-methoxypsoralen without UV light in murine melanoma cells. Pigment Cell Res 1994; 7:245-254.
21. SLOMINSKI A, PRUSKI D. Melatonin inhibits proliferation and melanogenesis in rodent melanoma cells. Exp Cell Res 1993; 206:189-194.
22. CASTRUCCI AML, ALMEIDA ALK, AL-OBEIDI FA et al. Comparative biological activities of α-MSH antagonists in vertebrate pigment cells. Gen Comp Endocrinol 1997; 105:410-416.
23. YING SW, NILES LP, CROCKER C. Human malignant melanoma cells express high affinity receptors for melatonin: antiproliferative effects of melatonin and 6-chloromelatonin. Eur J Pharmacol 1993; 246:89-96.
24. STANBERRY LR, DAS GUPTA TK, BEATTIE CW. Photoperiodic control of melanoma growth in hamsters: influence of pinealectomy and melatonin. Endocrinology 1983; 113:469-475.
25. ALMEIDA ALK. Efeitos in vivo e in vitro de melatonina sobre o crescimento tumoral, proliferação celular e melanogênese em melanoma S91 de Cloudman. Dissertação de mestrado, Instituto de Biociências da Universidade de São Paulo 1996: 106 pp.
26. HU DN, MCCORMICK SA, ROBERTS JE. Effects of melatonin, its precursors and derivatives on the growth of cultured human uveal melanoma cells. Melanoma Res 1998; 8:205-210.
27. WEAHTERHEAD B, BLACKBURN MEC. Growth and melanization of a hamster melanoma cell line, RPMI 3460, in response to melatonin and cyclic nucleotides. In: Pigment Cell: Biological, Molecular and Clinical Aspects of Pigmentation. BAGNARA J, KLAUS SN, PAUL E, SCHARTL M, eds., University of Tokyo Press, Tokyo, 1985; 774 pp.
28. KADEKARO AL. Receptor e mecanismo de ação de melatonina em células S91 de melanoma murino de Cloudman. Tese de doutorado, Instituto de Biociências da Universidade de São Paulo, São Paulo, 2000; 150 pp.
29. COS S, FERNANDEZ R, GUEZMES A, SANCHEZ-BARCELÓ EJ. Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells. Cancer Res 1998; 58:4383-4390.
30. COS S, RECIO J, SANCHEZ-BARCELÓ EJ. Modulation of the length of the cell cycle time of MCF-7 human breast cancer cells by melatonin. Life Sci 1996; 588:811-816.
31. COS S, FERNÁNDEZ R, SANCHEZ-BARCELÓ, EJ. Melatonin inhibits DNA synthesis in MCF-7 human breast cancer cells in vitro. Life Sci 1996; 58: 2447-2453.
32. COS S, MEDIAVILLA MD, FERNÁNDEZ R, GONZÁLEZ-LAMUND D, SANCHEZ-BARCELÓ EJ. Does melatonin induce apoptosis in MCF-7 human breast cells in vitro? J Pineal Res 2002; 32:90-96.
33. MEDIAVILLA MD, COS S, SANCHEZ-BARCELÓ, EJ. Melatonin increases p53 and p21WAF1 expression in MCF-7 human breast cancer cells. Life Sci 1999; 65: 415-420.
34. DAÍ J, INSCHO EW, YUAN L, HILL SM. Modulation of intracelular calcium and calmodulin by melatonin in MCF-7 human breast cancer cells. J Pineal Res 2002; 32: 112-119.
35. CINI G, COONELLO M, MINI E, NERI B. Melatonin's growth inhibitory effect on hepatoma AH 130 in the rat. Cancer Lett 1998; 125: 51-59.
36. PETRANKA J, BALDWIN W, BIERMANN J, JAYADEV S, BARRETT JC, MURPHY EE. The oncostatic action of melatonin in an ovarian carcinoma cell line. J Pineal Res 1991; 26: 129-136.
37. MARELLI MM, LIMONTA P, MAGGI R, MOTTA M, MORETTI RM. Growth-inhibitory activity of melatonin on human androgen-independent DU 145 prostate cancer cells. Prostate 2000; 45: 238-244.
38. BLASK DE, SAUER LA, DAUCHY RT. Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy. Curr Top Med Chem 2002; 2: 113-132.
39. 125 I]-iodomelatonin binding sites in Djungarian hamster brain. Endocrinology 1989; 125:1011-1018.
40. EISON AS, MULLINS UL. Melatonin binding sites are functionally coupled to phosphoinositide hydrolysis in Syrian hamster RPMI 1846 melanoma cells. Life Sci 1993; 53:393-398.
41. HELTON RA, HARRISON WA, KELLEY K, KANE MA. Melatonin interactions with cultured murine B16 melanoma cells. Melanoma Res 1993; 3:403-413.
42. 1b, recombinant subtypes are used to assess the pharmacological profile of the rabbit retina ML1 presynaptic heteroreceptor. Naunyn-Schmiedeberg's Arch Pharmacol 1997; 355:365-375.
43. LISSONI P, BARNI S, CATTANEO G et al. Clinical results with the pineal hormone melatonin in advanced cancer resistant to standard antitumor therapies. Oncology 1991; 48: 448-450.
44. LISSONI P, BRIVIO O, BRIVlO F et al. Adjuvant therapy with the pineal hormone melatonin in patients with lymph node relapse due to malignant melanoma. J Pineal Res 1996; 21: 239-242.